Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses

Chromothripsis is a catastrophic event involving numerous chromosomal rearrangements in confined genomic regions of one or a few chromosomes, causing complex effects on cells via the extensive structural variation. The development of whole-genome sequencing (WGS) has promoted great progress in explo...

Full description

Bibliographic Details
Main Authors: Qin Zhang, Lujie Yang, He Xiao, Zhaoqian Dang, Xunjie Kuang, Yanli Xiong, Jianwu Zhu, Zhou Huang, Mengxia Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1074955/full
_version_ 1797944937798434816
author Qin Zhang
Lujie Yang
He Xiao
Zhaoqian Dang
Xunjie Kuang
Yanli Xiong
Jianwu Zhu
Zhou Huang
Mengxia Li
author_facet Qin Zhang
Lujie Yang
He Xiao
Zhaoqian Dang
Xunjie Kuang
Yanli Xiong
Jianwu Zhu
Zhou Huang
Mengxia Li
author_sort Qin Zhang
collection DOAJ
description Chromothripsis is a catastrophic event involving numerous chromosomal rearrangements in confined genomic regions of one or a few chromosomes, causing complex effects on cells via the extensive structural variation. The development of whole-genome sequencing (WGS) has promoted great progress in exploring the mechanism and effect of chromothripsis. However, the gene expression characteristics of tumors undergone chromothripsis have not been well characterized. In this study, we found that the transcriptional profile of five tumor types experiencing chromothripsis is associated with an immune evasion phenotype. A gene set variation analysis (GSVA) was used to develop a CHP score, which is based on differentially expressed gene sets in the TCGA database, revealing that chromothripsis status in multiple cancers is consistent with an abnormal tumor immune microenvironment and immune cell cytotoxicity. Evaluation using four immunotherapy datasets uncovered the ability of the CHP score to predict immunotherapy response in diverse tumor types. In addition, the CHP score was found to be related to resistance against a variety of anti-tumor drugs, including anti-angiogenesis inhibitors and platinum genotoxins, while EGFR pathway inhibitors were found to possibly be sensitizers for high CHP score tumors. Univariate COX regression analysis indicated that the CHP score can be prognostic for several types of tumors. Our study has defined gene expression characteristics of tumors with chromothripsis, supporting the controversial link between chromothripsis and tumor immunity. We also describe the potential value of the CHP score in predicting the efficacy of immunotherapy and other treatments, elevating chromothripsis as a tool in clinical practice.
first_indexed 2024-04-10T20:47:30Z
format Article
id doaj.art-ef83d82d4ae74e46b4a7bf123fcb349e
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T20:47:30Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-ef83d82d4ae74e46b4a7bf123fcb349e2023-01-24T07:31:45ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011310.3389/fonc.2023.10749551074955Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responsesQin ZhangLujie YangHe XiaoZhaoqian DangXunjie KuangYanli XiongJianwu ZhuZhou HuangMengxia LiChromothripsis is a catastrophic event involving numerous chromosomal rearrangements in confined genomic regions of one or a few chromosomes, causing complex effects on cells via the extensive structural variation. The development of whole-genome sequencing (WGS) has promoted great progress in exploring the mechanism and effect of chromothripsis. However, the gene expression characteristics of tumors undergone chromothripsis have not been well characterized. In this study, we found that the transcriptional profile of five tumor types experiencing chromothripsis is associated with an immune evasion phenotype. A gene set variation analysis (GSVA) was used to develop a CHP score, which is based on differentially expressed gene sets in the TCGA database, revealing that chromothripsis status in multiple cancers is consistent with an abnormal tumor immune microenvironment and immune cell cytotoxicity. Evaluation using four immunotherapy datasets uncovered the ability of the CHP score to predict immunotherapy response in diverse tumor types. In addition, the CHP score was found to be related to resistance against a variety of anti-tumor drugs, including anti-angiogenesis inhibitors and platinum genotoxins, while EGFR pathway inhibitors were found to possibly be sensitizers for high CHP score tumors. Univariate COX regression analysis indicated that the CHP score can be prognostic for several types of tumors. Our study has defined gene expression characteristics of tumors with chromothripsis, supporting the controversial link between chromothripsis and tumor immunity. We also describe the potential value of the CHP score in predicting the efficacy of immunotherapy and other treatments, elevating chromothripsis as a tool in clinical practice.https://www.frontiersin.org/articles/10.3389/fonc.2023.1074955/fullchromothripsistumor immunitydrug resistanceprognosisimmune checkpoint inhibitors therapy
spellingShingle Qin Zhang
Lujie Yang
He Xiao
Zhaoqian Dang
Xunjie Kuang
Yanli Xiong
Jianwu Zhu
Zhou Huang
Mengxia Li
Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
Frontiers in Oncology
chromothripsis
tumor immunity
drug resistance
prognosis
immune checkpoint inhibitors therapy
title Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
title_full Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
title_fullStr Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
title_full_unstemmed Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
title_short Pan-cancer analysis of chromothripsis-related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
title_sort pan cancer analysis of chromothripsis related gene expression patterns indicates an association with tumor immune and therapeutic agent responses
topic chromothripsis
tumor immunity
drug resistance
prognosis
immune checkpoint inhibitors therapy
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1074955/full
work_keys_str_mv AT qinzhang pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT lujieyang pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT hexiao pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT zhaoqiandang pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT xunjiekuang pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT yanlixiong pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT jianwuzhu pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT zhouhuang pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses
AT mengxiali pancanceranalysisofchromothripsisrelatedgeneexpressionpatternsindicatesanassociationwithtumorimmuneandtherapeuticagentresponses